What is IRIX's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for IRIX?

P/E (TTM) is n/a and 52-week range is $0.61 to $1.65 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s IRIX figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for IRIX?

The company profile lists revenue (TTM) near $52M, net income (TTM) near $-355M, EPS (TTM) near $-0.21 when available from the market-data feed. Figures are informational and may lag live markets.

Where is IRIDEX Corp based, and what identifiers does Chartloom list?

The company context section lists headquarters in Mountain View, California, US, 17.4M shares outstanding, ISIN US4626841013 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

IRIDEX Corp

$IRIX

Health Care · Health Care Equipment & Supplies

IR Run Scenarios

$0.85

-8.69%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.

Employees

Website

www.iridex.com/

IPO

1996-02-16

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)